Last year, a 74-year old woman was diagnosed with inoperable pancreatic cancer. Her family turned to Miami Cancer Institute in their search for treatment options. Since her diagnosis, she became part of the TIGeR-PaC clinical trial, and is now in a maintenance phase and says her quality of life has improved.
New Pancreatic Cancer Treatment May Add Years to the Lives of Those Facing Death
Recent News
- RenovoRx Receives New 510(k) Clearance for its RenovoCath® Delivery System Designed for Targeted Treatment of Solid Tumors
- RenovoRx Receives New 510(k) Clearance for its RenovoCath® Delivery System Designed for Targeted Treatment of Solid Tumors
- RenovoRx Announces Pricing of Initial Public Offering
- RenovoRx Announces Pricing of Initial Public Offering
- RenovoRx Announces Issuance of Seventh U.S. Patent